Eden Research plc (LON:EDEN – Get Free Report) shot up 2.8% on Tuesday following insider buying activity. The stock traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). 12,234,783 shares traded hands during mid-day trading, an increase of 664% from the average session volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey acquired 540,540 shares of the business’s stock in a transaction on Tuesday, January 28th. The stock was bought at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($26,919.32).
Eden Research Stock Performance
The company has a market capitalization of £20.80 million, a P/E ratio of -200.00 and a beta of 0.92. The stock has a fifty day simple moving average of GBX 3.89 and a 200-day simple moving average of GBX 4.01. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.25.
Eden Research Company Profile
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Further Reading
- Five stocks we like better than Eden Research
- What is Forex and How Does it Work?
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- Insider Trading – What You Need to Know
- 3 Steel Stocks Soaring After Tariff Announcements
- Using the MarketBeat Dividend Tax Calculator
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.